Treatment of rat congenital diaphragmatic hernia with sildenafil and NS-304, selexipag's active compound, at the pseudoglandular stage improves lung vasculature

Daphne Mous; Heleen Kool; Petra Bürgisser; Marjon Buscop - van Kempen; Koji Nagata; Anne Boerema - de Munck; Joost van Rosmalen; O Dzyubachyk; Rene Wijnen; Dick Tibboel; Robbert Rottier

doi:10.1152/ajplung.00392.2017

Treatment of rat congenital diaphragmatic hernia with sildenafil and NS-304, selexipag's active compound, at the pseudoglandular stage improves lung vasculature

Daphne Mous, Heleen Kool, Petra Bürgisser, Marjon Buscop - van Kempen, Koji Nagata, Anne Boerema - de Munck, Joost van Rosmalen, O Dzyubachyk, Rene Wijnen, Dick Tibboel, Robbert Rottier

Research output: Contribution to journal › Article › Academic › peer-review

23 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	L276-L285
Journal	American Journal of Physiology-Lung Cellular and Molecular Physiology
Volume	315
Issue number	2
DOIs	https://doi.org/10.1152/ajplung.00392.2017
Publication status	Published - 2018

Research programs

EMC MGC-02-13-02
EMC MGC-02-53-01-A

Access to Document

10.1152/ajplung.00392.2017

http://hdl.handle.net/1765/114279

Cite this

Mous, D., Kool, H., Bürgisser, P., Buscop - van Kempen, M., Nagata, K., Boerema - de Munck, A., van Rosmalen, J., Dzyubachyk, O., Wijnen, R., Tibboel, D., & Rottier, R. (2018). Treatment of rat congenital diaphragmatic hernia with sildenafil and NS-304, selexipag's active compound, at the pseudoglandular stage improves lung vasculature. American Journal of Physiology-Lung Cellular and Molecular Physiology, 315(2), L276-L285. https://doi.org/10.1152/ajplung.00392.2017

@article{de5f72bfc7d5468699c402bb08a160a2,

title = "Treatment of rat congenital diaphragmatic hernia with sildenafil and NS-304, selexipag's active compound, at the pseudoglandular stage improves lung vasculature",

author = "Daphne Mous and Heleen Kool and Petra B{\"u}rgisser and {Buscop - van Kempen}, Marjon and Koji Nagata and {Boerema - de Munck}, Anne and {van Rosmalen}, Joost and O Dzyubachyk and Rene Wijnen and Dick Tibboel and Robbert Rottier",

year = "2018",

doi = "10.1152/ajplung.00392.2017",

language = "Undefined/Unknown",

volume = "315",

pages = "L276--L285",

journal = "American Journal of Physiology-Lung Cellular and Molecular Physiology",

issn = "1040-0605",

publisher = "American Physiological Society",

number = "2",

}

Mous, D, Kool, H, Bürgisser, P , Buscop - van Kempen, M, Nagata, K, Boerema - de Munck, A, van Rosmalen, J, Dzyubachyk, O, Wijnen, R , Tibboel, D & Rottier, R 2018, 'Treatment of rat congenital diaphragmatic hernia with sildenafil and NS-304, selexipag's active compound, at the pseudoglandular stage improves lung vasculature', American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 315, no. 2, pp. L276-L285. https://doi.org/10.1152/ajplung.00392.2017

Treatment of rat congenital diaphragmatic hernia with sildenafil and NS-304, selexipag's active compound, at the pseudoglandular stage improves lung vasculature. / Mous, Daphne; Kool, Heleen; Bürgisser, Petra et al.
In: American Journal of Physiology-Lung Cellular and Molecular Physiology, Vol. 315, No. 2, 2018, p. L276-L285.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Treatment of rat congenital diaphragmatic hernia with sildenafil and NS-304, selexipag's active compound, at the pseudoglandular stage improves lung vasculature

AU - Mous, Daphne

AU - Kool, Heleen

AU - Bürgisser, Petra

AU - Buscop - van Kempen, Marjon

AU - Nagata, Koji

AU - Boerema - de Munck, Anne

AU - van Rosmalen, Joost

AU - Dzyubachyk, O

AU - Wijnen, Rene

AU - Tibboel, Dick

AU - Rottier, Robbert

PY - 2018

Y1 - 2018

U2 - 10.1152/ajplung.00392.2017

DO - 10.1152/ajplung.00392.2017

M3 - Article

C2 - 29745254

SN - 1040-0605

VL - 315

SP - L276-L285

JO - American Journal of Physiology-Lung Cellular and Molecular Physiology

JF - American Journal of Physiology-Lung Cellular and Molecular Physiology

IS - 2

ER -

Mous D, Kool H, Bürgisser P , Buscop - van Kempen M, Nagata K, Boerema - de Munck A et al. Treatment of rat congenital diaphragmatic hernia with sildenafil and NS-304, selexipag's active compound, at the pseudoglandular stage improves lung vasculature. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2018;315(2):L276-L285. doi: 10.1152/ajplung.00392.2017